S&P 500
5,888.55
-0.6%
-$32.99
DJI
42,098.70
-0.6%
-$244.95
NASDAQ
19,100.94
-0.5%
-$98.23
Bitcoin
107,873.00
-0.9%
-989.23
AAPL
$200.40
+0.1%
+$0.19
AMZN
$204.64
-0.7%
-$1.38
GOOG
$173.28
-0.4%
-$0.70
META
$643.48
+0.2%
+$1.16
MSFT
$457.40
-0.7%
-$3.28
NVDA
$135.14
-0.3%
-$0.36
TSLA
$356.97
-1.6%
-$5.92
Verseon (LSE: VSN)
Some price data may be temporarily unavailable.
Verseon Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Verseon Company Info
Verseon is a technology-based pharmaceutical company developing novel therapeutics for today’s challenging diseases. The company’s proprietary drug discovery platform is the first systematic, computationally-driven solution to achieve the molecular modeling accuracy necessary for rapid and cost-effective drug discovery. Verseon plans to use its platform to establish a diversified discovery pipeline across multiple disease areas. It was founded in 2002 and is headquartered in Fremont, California.
News & Analysis
No articles found.
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.